Related Experiment Video
Updated: Sep 19, 2025

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
Published on: June 28, 2021
A Mendelian randomization study investigating the causal effect of simvastatin consumption on pancreatitis risk
Wenfeng Lin1, Qiqi Zheng2, Maddalena Zippi3
1Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
Background:
Simvastatin has been inconsistently linked to pancreatitis. We employed Mendelian Randomization (MR) as a pathway to ascertain this potential causal connection among simvastatin consumption and likelihood of pancreatitis onset.
Methods:
UK Biobank was employed to pinpoint genetic variations. Related to simvastatin. Information on acute (AP) and chronic (CP) pancreatitis has been obtained from the European ancestry, FinnGen consortium, and East Asian people. Univariate and multivariate MR analyses have been performed.
Results:
In European populations, inverse variance weighted (IVW) analysis revealed no significant causal association between simvastatin use and acute pancreatitis (AP, P = 0.129) or chronic pancreatitis (CP, P = 0.430). Consistent null effects were observed across sensitivity analyses using MR-Egger, weighted median, and leave-one-out (LOO) methods. Multivariable MR adjusted for alcohol use and cholelithiasis similarly showed no direct effects (AP: P = 0.744; CP: P = 0.183). Replication analyses using GWAS data from FinnGen Consortium (IVW: AP P = 0.070; CP P = 0.939) and East Asian cohorts (IVW: AP P = 0.325; CP P = 0.907) confirmed these patterns. All sensitivity methods (MR-Egger/weighted median/LOO) yielded concordant results across cohorts. Multivariable MR outcomes remained aligned with primary findings after confounder adjustment.
Conclusions:
Genetic evidence has not proven a causality between simvastatin and pancreatitis, suggesting that routine monitoring may be unnecessary.
Insights
This study found no causal link between simvastatin use and pancreatitis using genetic analysis. Routine monitoring for pancreatitis in simvastatin users may not be necessary.
Area of Science:
- Pharmacogenetics
- Gastroenterology
- Epidemiology
Background:
- Simvastatin is a widely used cholesterol-lowering drug.
- Previous studies have shown inconsistent associations between simvastatin and pancreatitis.
- Mendelian Randomization (MR) offers a robust method to investigate potential causal relationships.
Purpose of the Study:
- To determine if simvastatin use causally increases the risk of pancreatitis.
- To investigate the association between simvastatin and both acute pancreatitis (AP) and chronic pancreatitis (CP).
Main Methods:
- Utilized UK Biobank for genetic variation identification related to simvastatin.
- Obtained pancreatitis data from European, FinnGen, and East Asian cohorts.
- Performed univariate and multivariate Mendelian Randomization analyses, including sensitivity tests.
Main Results:
- No significant causal association was found between simvastatin use and AP or CP in European populations (P > 0.129 for AP, P > 0.430 for CP).
- Sensitivity analyses (MR-Egger, weighted median, LOO) and multivariable MR adjusting for confounders confirmed these null findings.
- Replication analyses in FinnGen and East Asian cohorts corroborated the absence of a causal link.
Conclusions:
- Genetic evidence does not support a causal relationship between simvastatin and pancreatitis.
- Routine monitoring for pancreatitis in patients taking simvastatin is likely unnecessary.
More Related Videos
07:10Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
Published on: April 1, 2022
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
What is an Experiment?
Chronic Pancreatitis II: Collaborative Care
Assessment:
Randomized Experiments
Simple randomization
Simple...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...